Visualizaciones | |
---|---|
Unlocking Bevacizumab's Potential: rCBVmax as a Predictive Biomarker for Enhanced Survival in Glioblastoma IDH-Wildtype Patients | 65 |
noviembre 2023 | diciembre 2023 | enero 2024 | febrero 2024 | marzo 2024 | abril 2024 | mayo 2024 | |
---|---|---|---|---|---|---|---|
Unlocking Bevacizumab's Potential: rCBVmax as a Predictive Biomarker for Enhanced Survival in Glioblastoma IDH-Wildtype Patients | 0 | 0 | 0 | 0 | 0 | 62 | 3 |
Visualizaciones | |
---|---|
Alvarez-TorresBalanaFuster - Unlocking Bevacizumabs Potential rCBVsubmaxsub as a Predictive Bioma....pdf | 14 |
Visualizaciones | |
---|---|
Estados Unidos | 36 |
Alemania | 5 |
Francia | 5 |
España | 4 |
China | 2 |
Reino Unido | 2 |
Irlanda | 2 |
Nueva Zelanda | 2 |
Bulgaria | 1 |
Irán | 1 |
Visualizaciones | |
---|---|
Houston | 12 |
Mountain View | 6 |
Ashburn | 3 |
Auckland | 2 |
Jiujiang | 2 |
Menlo Park | 2 |
Portsmouth | 2 |
Pride | 2 |
Sarón | 2 |
Arezzo | 1 |